相关实验视频

Updated: May 12, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

卢拉西用于伴随性焦虑症状的双相I型抑郁症:随机,安慰剂控制的随机研究的后期分析

Takeshi Inoue¹, Takahiro Masuda², Fumiya Sano³

¹Department of Psychiatry, Tokyo Medical University, Tokyo, Japan; Department of Psychiatry, Sapporo Hanazono Hospital, Sapporo, Japan.

Journal of affective disorders

|May 7, 2025

概括

卢拉西有效地治疗双极性抑郁症,即使是严重的焦虑. 这种药物在患有双相I型抑郁症的患者中显示出良好的安全性,无论焦虑症状的严重程度如何.

科学领域:

精神病学是一个精神病学.
药理学药理学是指药理学的学科.

背景情况:

焦虑并发症在双相情感障碍中很普遍,通常会使症状恶化并降低治疗效果.
评估卢拉西在两极性抑郁症和不同焦虑水平的疗效至关重要.

研究的目的:

为了评估卢拉西在双相I型抑郁症患者的疗效和安全性,有或没有严重的焦虑.
为了确定焦虑的严重程度是否会影响卢拉西的有效性.

主要方法:

从两项双盲,随机双相I型抑郁症研究中汇集了数据.
患者接受了为期6周的卢拉西 (20-60毫克/天或80-120毫克/天) 或安慰剂治疗.
分类为严重 (汉密尔顿焦虑评分表[HAM-A] ≥18) 和不严重 (HAM-A <18) 的焦虑组.

主要成果:

卢拉西20-60毫克/天在严重焦虑组 (效果大小为0.40) 的蒙哥马利-阿斯伯格抑郁评分表 (MADRS) 评分显著改善.
卢拉西的两种剂量都在不严重的焦虑组中有效 (效果大小为0.51和0.54).
不良事件,如 akathisia 和恶心是常见的; 实验室和体重变化没有临床意义.

结论:

卢拉西20-60毫克/天对双相I型抑郁症是有效的,无论焦虑的严重程度如何.
在这项短期分析中,该药物表现出了有利的安全性.
这项后期分析支持卢拉西在广泛的双极性抑郁症患者中具有实用性.

关键词:

非典型的抗精神病药物.双极性抑郁症是一种双极性抑郁症.伴随性焦虑症的症状包括:卢拉西多尼的一种Lurasidone.

更多相关视频

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders

Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders

Published on: December 4, 2014

相关概念视频

Anxiolytic Drugs: Benzodiazepines and Buspirone

Anxiolytic Drugs: Benzodiazepines and Buspirone

Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Mania and Antimanic Drugs: Overview

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...

Drugs for Treatment of Diarrhea-Predominant IBS

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

Drugs for Treatment of Constipation-Predominant IBS

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...

Anxiolytic Drugs: Overview

Anxiolytic Drugs: Overview

Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...